Patients with cancer often suffer shortness of breath for different reasons. Many physicians prescribe empirical dexamethasone as a symptomatic treatment. In a randomized study conducted at MD Anderson cancer center, and published in The Lancet Oncology, high dose #Dexamethasone failed to improve dyspnoea scores in patients with cancer compared to placebo
Patients with cancer often suffer shortness of breath for different reasons. Many physicians prescribe empirical dexamethasone as a symptomatic treatment. In a randomized study conducted at MD Anderson cancer center, and published in The Lancet Oncology, high dose #Dexamethasone failed to improve dyspnoea scores in patients with cancer compared to placebo
.png)